Skip to main content
UNION KOREA PHARM CO.,Ltd logo

UNION KOREA PHARM CO.,Ltd — Investor Relations & Filings

Ticker · 080720 ISIN · KR7080720006 KO Manufacturing
Open in API
Filings indexed 431 across all filing types
Latest filing 2026-06-04 Director's Dealing
Country KR South Korea
Listing KO 080720

About UNION KOREA PHARM CO.,Ltd

https://ukp.co.kr/

UNION KOREA PHARM CO.,Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and distribution of prescription drugs. The company produces a range of specialty medicines in various formulations, including solid dosage forms, liquid injections, and powders. Its product portfolio addresses therapeutic areas such as neoplasms, immune system diseases, anti-inflammatory analgesics, antibiotics, and skeletal muscle relaxants. The company emphasizes strict quality control throughout the entire production cycle, from raw materials to shipping, to ensure its products meet Good Manufacturing Practice (GMP) standards. It operates in both domestic and international markets.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 92% confidence The document is a mandatory securities ownership report by an executive and major shareholder (“임원·주요주주 특정증권등 소유상황보고서”) detailing the acquisition of shares through a third-party allotment capital increase, including specific dates, share counts, and ownership percentages. This is a personal insider transaction filing by company officers/major shareholders rather than a corporate share buyback, threshold notification only, or regulatory certification. Therefore it fits the Director’s Dealing category (insider share transactions).
2026-06-04 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 93% confidence The document is a statutory disclosure titled “주식등의 대량보유상황보고서(일반)” detailing a change in significant share ownership (acquisition of 60,000,000 shares for 75.14% stake) by Bukwang Pharmaceutical in Korean Union Pharmaceutical. It matches the Major Shareholding Notification category for reporting threshold-crossing ownership changes.
2026-06-04 Korean
증권발행결과(자율공시) (제3자배정 유상증자)
Share Issue/Capital Change Classification · 90% confidence The document is a voluntary disclosure detailing the results of a third-party allotment capital increase, including type of securities, number of shares issued, amount raised, board resolution date, subscription date, and listing plans. This fits the definition of a Share Issue/Capital Change announcement (SHA).
2026-05-27 Korean
최대주주변경
Major Shareholding Notification Classification · 90% confidence The document is a regulatory disclosure announcing a change in the company’s major shareholder (최대주주 변경). It provides before-and-after ownership percentages, reasons for the share allocation, details of the new shareholder corporation, and its financials. This fits the definition of a Major Shareholding Notification (Code: MRQ), which covers notifications of changes in significant share ownership levels.
2026-05-27 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 95% confidence The document is a "주식등의 대량보유상황보고서(약식)"—a statutory simplified large shareholding report filed by an individual shareholder under Korean capital markets law. It details the number of shares held, percentage ownership, changes due to a judicial rehabilitation plan conversion, and other major shareholding particulars. This matches the definition of a Major Shareholding Notification (MRQ).
2026-05-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 92% confidence The document is a statutory report titled “임원ㆍ주요주주 특정증권등 소유상황보고서” (Report of specific securities holdings for officers and major shareholders), filed with the Korean Financial Supervisory Commission and Korea Exchange. It details changes in holdings of an officer/major shareholder (박광석), including acquisition/disposition of shares and ownership percentages. This corresponds to an insider share transaction report (insider dealing by directors/executives). Therefore, it should be classified under Director’s Dealing (DIRS).
2026-05-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.